Clinical implications of serum GDF15 propeptide as a biomarker for bone metastasis across common solid tumors: a real-world multi-institutional study.

Yamamichi G, Kato T, Matsukawa A, Masunaga N, Hirata H, Okuno J, Kawamura N, Kunimasa K, Seto I, Kin T, Masuhiro K, Sato S, Myoba S, Ikeda S, Ujike T, Ishizuya Y, Hayashi T, Yamamoto Y, Hatano K, Kawashima A, Miyagi Y, Uemura M, Nishino K, Nakayama T, Nakayama M, Takeda Y, Shimazu K, Nonomura N

Open source

DOI
10.1186/s40364-026-00982-4
Published
2026 Aug 12
Container
Biomarker research
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1186/s40364-026-00982-4,
  title = {Clinical implications of serum GDF15 propeptide as a biomarker for bone metastasis across common solid tumors: a real-world multi-institutional study.},
  author = {Yamamichi G and Kato T and Matsukawa A and Masunaga N and Hirata H and Okuno J and Kawamura N and Kunimasa K and Seto I and Kin T and Masuhiro K and Sato S and Myoba S and Ikeda S and Ujike T and Ishizuya Y and Hayashi T and Yamamoto Y and Hatano K and Kawashima A and Miyagi Y and Uemura M and Nishino K and Nakayama T and Nakayama M and Takeda Y and Shimazu K and Nonomura N},
  year = {2026},
  journal = {Biomarker research},
  doi = {10.1186/s40364-026-00982-4},
  url = {https://doi.org/10.1186/s40364-026-00982-4}
}

RIS

TY  - JOUR
TI  - Clinical implications of serum GDF15 propeptide as a biomarker for bone metastasis across common solid tumors: a real-world multi-institutional study.
AU  - Yamamichi G
AU  - Kato T
AU  - Matsukawa A
AU  - Masunaga N
AU  - Hirata H
AU  - Okuno J
AU  - Kawamura N
AU  - Kunimasa K
AU  - Seto I
AU  - Kin T
AU  - Masuhiro K
AU  - Sato S
AU  - Myoba S
AU  - Ikeda S
AU  - Ujike T
AU  - Ishizuya Y
AU  - Hayashi T
AU  - Yamamoto Y
AU  - Hatano K
AU  - Kawashima A
AU  - Miyagi Y
AU  - Uemura M
AU  - Nishino K
AU  - Nakayama T
AU  - Nakayama M
AU  - Takeda Y
AU  - Shimazu K
AU  - Nonomura N
PY  - 2026
JO  - Biomarker research
DO  - 10.1186/s40364-026-00982-4
UR  - https://doi.org/10.1186/s40364-026-00982-4
ER  - 

APA

G, Y., T, K., A, M., N, M., H, H., J, O., N, K., K, K., I, S., T, K., K, M., S, S., S, M., S, I., T, U., Y, I., T, H., Y, Y., K, H., A, K., Y, M., M, U., K, N., T, N., M, N., Y, T., K, S., & N, N. (2026). Clinical implications of serum GDF15 propeptide as a biomarker for bone metastasis across common solid tumors: a real-world multi-institutional study.. Biomarker research. https://doi.org/10.1186/s40364-026-00982-4

Source records